Insider Transactions in Q2 2022 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2022
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-0.2%
|
$0
$0.39 P/Share
|
|
Jun 30
2022
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,719
-0.76%
|
$0
$0.39 P/Share
|
|
Jun 30
2022
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
1,813
-0.77%
|
$0
$0.39 P/Share
|
|
Jun 30
2022
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,683
-1.01%
|
$0
$0.39 P/Share
|
|
May 31
2022
|
David Domzalski PRESIDENT AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
11,887
+1.11%
|
$0
$0.35 P/Share
|
|
May 31
2022
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,510
+6.71%
|
$0
$0.35 P/Share
|